Astellas Pharma (4503.T) Price-to-Earnings (P/E) Ratio

Price: $1435
Market Cap: $2.57T
Avg Volume: 6.89M
Country: JP
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.166
52W Range: $1243.5-1835
Website: Astellas Pharma

Price-to-Earnings (P/E) Ratio Summary

Astellas Pharma's P/E ratios across different time periods:

  • TTM: -44.72
  • Annual: 172.65
  • Quarterly: -7.03

What is P/E Ratio?

The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.

Related Metrics

  • Price-to-Book (P/B) Ratio: 1.84
  • Price-to-Sales (P/S) Ratio: 1.84

Annual Ratios

Astellas Pharma Historical P/E Ratio

198.54198.54178.69178.69158.84158.84138.98138.98119.13119.1399.2799.2779.4279.4259.5659.5639.7139.7119.8519.850.000.00P/E Ratio172.6534.7228.4926.2116.0414.7319.9014.1416.6731.9930.2627.4020.0721.0312.792011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024

Historical P/B Ratio

3.793.793.413.413.033.032.652.652.282.281.901.901.521.521.141.140.760.760.380.380.000.00P/B Ratio1.842.272.422.282.432.602.582.432.563.302.172.141.541.391.482011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024

Historical P/S Ratio

4.014.013.613.613.213.212.812.812.402.402.002.001.601.601.201.200.800.800.400.400.000.00P/S Ratio1.842.262.732.532.412.512.522.362.353.482.412.261.621.491.602011201120122012201320132014201420152015201620162017201720182018201920192020202020212021202220222023202320242024

TTM P/E Ratio

-44.72

P/B Ratio (Annual)

1.84

P/S Ratio (Annual)

1.84

Astellas Pharma Historical Valuation Metrics

The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.

Year P/E Ratio P/B Ratio P/S Ratio
2024 172.65 1.84 1.84
2023 34.72 2.27 2.26
2022 28.49 2.42 2.73
2021 26.21 2.28 2.53
2020 16.04 2.43 2.41
2019 14.73 2.60 2.51
2018 19.90 2.58 2.52
2017 14.14 2.43 2.36
2016 16.67 2.56 2.35
2015 31.99 3.30 3.48
2014 30.26 2.17 2.41
2013 27.40 2.14 2.26
2012 20.07 1.54 1.62
2011 21.03 1.39 1.49
2010 12.79 1.48 1.60

Related Metrics

Explore detailed financial metrics and analysis for 4503.T.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio